BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18415952)

  • 1. Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling.
    Appleton DL; Abbate A; Biondi-Zoccai GG
    Catheter Cardiovasc Interv; 2008 May; 71(6):772-81. PubMed ID: 18415952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late percutaneous recanalization of totally occluded infarct-related arteries--more than about time.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2008 May; 71(6):782-3. PubMed ID: 18415953
    [No Abstract]   [Full Text] [Related]  

  • 3. Late percutaneous coronary intervention for an occluded infarct-related artery in patients with preserved infarct zone viability: a pooled analysis of cardiovascular magnetic resonance studies.
    Małek LA; Silva JC; Bellenger NG; Nicolau JC; Kłopotowski M; Spiewak M; Rassi CH; Lewandowski Z; Kruk M; Rochitte CE; Rużyłło W; Witkowski A
    Cardiol J; 2013; 20(5):552-9. PubMed ID: 24297771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials.
    Abbate A; Biondi-Zoccai GG; Appleton DL; Erne P; Schoenenberger AW; Lipinski MJ; Agostoni P; Sheiban I; Vetrovec GW
    J Am Coll Cardiol; 2008 Mar; 51(9):956-64. PubMed ID: 18308165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
    Kruk M; Kadziela J; Reynolds HR; Forman SA; Sadowski Z; Barton BA; Mark DB; Maggioni AP; Leor J; Webb JG; Kapeliovich M; Marin-Neto JA; White HD; Lamas GA; Hochman JS
    JACC Cardiovasc Interv; 2008 Oct; 1(5):511-20. PubMed ID: 19194534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    van der Schaaf RJ; Claessen BE; Hoebers LP; Verouden NJ; Koolen JJ; Suttorp MJ; Barbato E; Bax M; Strauss BH; Olivecrona GK; Tuseth V; Glogar D; Råmunddal T; Tijssen JG; Piek JJ; Henriques JP;
    Trials; 2010 Sep; 11():89. PubMed ID: 20858263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.
    Dzavík V; Buller CE; Lamas GA; Rankin JM; Mancini GB; Cantor WJ; Carere RJ; Ross JR; Atchison D; Forman S; Thomas B; Buszman P; Vozzi C; Glanz A; Cohen EA; Meciar P; Devlin G; Mascette A; Sopko G; Knatterud GL; Hochman JS;
    Circulation; 2006 Dec; 114(23):2449-57. PubMed ID: 17105848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well-Developed Collaterals.
    Choi SY; Choi BG; Rha SW; Baek MJ; Ryu YG; Park Y; Byun JK; Shim M; Li H; Mashaly A; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of delayed opening of infarct-related artery on late left ventricular remodeling in patients with acute anterior myocardial infarction].
    Ma LK; Yu H; Huang XY; Zhu J; Feng KF; Li SG; Zhang XH; Shao ZB; Ding XM; Yan J; Gu TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):328-31. PubMed ID: 15932662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.
    Claessen BE; van der Schaaf RJ; Verouden NJ; Stegenga NK; Engstrom AE; Sjauw KD; Kikkert WJ; Vis MM; Baan J; Koch KT; de Winter RJ; Tijssen JG; Piek JJ; Henriques JP
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1128-34. PubMed ID: 19926056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction.
    Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G
    Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of ischemic mitral regurgitation during the acute phase of ST elevation myocardial infarction treated with primary coronary intervention for left ventricular remodeling in long-term follow-up.
    Wita K; Berger-Kucza A; Filipecki A; Turski M; Bochenek T; Wróbel W; Lelek M; Weglarz P; Elzbieciak M; Trusz-Gluza M
    Coron Artery Dis; 2010 Sep; 21(6):325-9. PubMed ID: 20453641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion grade after late infarct artery recanalization is associated with global and regional left ventricular function at one year: analysis from the Total Occlusion Study of Canada-2.
    Steigen TK; Buller CE; Mancini GB; Jorapur V; Cantor WJ; Rankin JM; Thomas B; Webb JG; Kronsberg SS; Atchison DJ; Lamas GA; Hochman JS; Džavík V
    Circ Cardiovasc Interv; 2010 Dec; 3(6):549-55. PubMed ID: 21062997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial.
    Garzillo CL; Hueb W; Gersh BJ; Lima EG; Rezende PC; Hueb AC; Vieira RD; Favarato D; Pereira AC; Soares PR; Serrano CV; Ramires JA; Kalil Filho R
    Eur Heart J; 2013 Nov; 34(43):3370-7. PubMed ID: 23828828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
    Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy.
    Wöhrle J; Merkle N; Kunze M; Cristea E; Mehran R; Rottbauer W; Stone GW
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1083-9. PubMed ID: 22162175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.